Stocks to Watch: nCoat, Inc. (OTCBB: NCOA), General Metals Corporation (OTC BB:GNMT) , NPS Pharmaceuticals, Inc. (Nasdaq:NPSP) , Defense Industries International, Inc. (OTC BB:DFNS) , Ampex Corporation (Nasdaq:AMPX)
Featured Stock: nCoat, Inc.
(OTCBB: NCOA)
Current Price (0.60)
www.wallstreetstockreview.com
nCoat Subsidiary HPC Provides Heat Management Coating Aimed at Boosting Aftermarket Turbocharger Sales
Whitsett, NC, --– July 23, 2007 -- nCoat, Inc. (OTC BB: NCOA) ("nCoat" or the "Company") has introduced through its operating subsidiary, High Performance Coatings (HPC), a heat and corrosion management coating for Squires Turbo Systems (STS) of Orem, Utah (www.STSTurbo.com) for all turbo pipe connections from manufacturers engines to Squires rear mounted turbochargers. STS produces the only remote turbocharger system for multiple makes and models of performance automobiles. HPC coats STS turbo parts with a highly burnished, heat management coating that maintains an exceptionally bright appearance that does not tarnish with use while helping manage the extreme heat produced in turbocharger environments.
Founded by Rick Squires in 2003, STS is revolutionizing the aftermarket performance industry with patented remote mounted turbo systems for cars, trucks and SUVs. Remote mounted turbo systems are superior to traditional turbo systems and superchargers because they are efficient, less intrusive, easy to install, reliable and generate amazing horsepower and torque. Turbo systems generate usable horsepower boost between 2500 and 5000 rpm. Because STS turbo systems have significantly lower Intake Air Temperatures, STS remote mounted turbo systems often generate more horsepower per pound of boost than front mounted turbo systems. STS turbo systems are one of the few turbo systems that are legal in all 50 states.
“When someone buys a high-end exhaust system, they expect a high-gloss finish.” said Rick Squires, Vice President of Research and Development at STS Turbo. “But more importantly, they also expect that finish to last. STS uses HPC’s H05 coating on its turbo kits. These coatings are durable and functional with a high level of malleability and excellent adhesion.”
The H05 coating is part of HPC’s “H Series” coatings that allow engine parts to maintain a uniform temperature over the entire area of the underlying material. When the coatings are used in high temperature exhaust gas path applications, the temperature in the tube is maintained uniformly throughout the pipe, decreasing the low air density. Increased gas path temperatures and decreased pressures assist increased engine efficiencies. Using HPC H05 coating, Squires reports that its turbo kits can deliver 5-20 psi of boost. STS switched to HPC coating processes after conventional chrome finishes could not withstand high temperatures.
“HPC coats approximately 80 parts for STS Turbo per week, said Paul Clayson, CEO of HPC parent company, nCoat. “The volume through-put of our plants can easily meet the demands of multiple accounts of this size and larger. When performance leaders need results, they turn to HPC.”
HPC’s innovative coatings technologies, including many nano-technology applications, provide a high gloss performance finish that maintains luster under high heat conditions. HPC’s engineering, research and development departments provide cutting edge coatings that can perform at the increasingly stringent demands of today’s environments.
About HPC, Inc.
High Performance Coatings, Inc., a wholly-owned subsidiary of nCoat, has been an integral part of the automotive motor sports industry since 1982. The company has coated parts for multiple Motor sport Hall of Fame inductees and land and air speed world record holders. This rich racing heritage has led HPC to be nicknamed 'The Choice of World Champions.' HPC develops, manufactures, and applies coating (surface treatment) solutions for thermal management, anti-corrosion, friction reduction, bond strength, and appearance. HPC is a particular market leader in internal and external engine parts coatings in automotive and diesel engines. At HPC, there IS a difference...and the difference is superior performance.
About nCoat, Inc.
Formed in 2004, nCoat, Inc. is an emerging nanotechnology company with new nano-formulated and traditional coatings that make it an international leader in the development and marketing of coatings applied to metal, ceramics, fabric, and other materials. The company specializes in nanotechnology research, commercialization, licensing, and distribution, and through its subsidiary companies develops and distributes commercially viable proprietary nanotechnology and traditional coatings products. At nCoat, we invite the world to "Innovate with us..."
Notice Regarding Forward-Looking Statements
Except for statements of historical fact, the information presented herein may contain forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to acquire and develop specific projects, the ability to fund operations and changes in consumer and business consumption habits and other factors over which nCoat, Inc. has little or no control. Statements in this press release which include words such as "anticipates," "plans," "potential," and similar terms may include forward-looking statements. Factors which could cause the Company's results to differ from the forward-looking statements include a decline or slower-than-anticipated growth in revenue opportunities related to the performance coating industry, and a decline or slower-than-anticipated growth in the demand and use for nano-formulated commercial products and related revenue streams for the Company, as well as listed in the "Risk Factors" sections of the Company's publicly filed reports. The Company expressly disclaims any obligation or intention to update any forward-looking statement.
ON BEHALF OF THE BOARD
nCoat, Inc.
Paul S. Clayson, Chief Executive Officer
Investor Relations Contact:
Brad Long. 1-866-435-8958 blong@ncoat.com
Visit our website at www.ncoat.com
For an in-depth analyst report, please visit: www.wallstreetstockreview.com
General Metals Corporation
(OTC BB:GNMT)
Current Price (0.30)
www.wallstreetstockreview.com
RENO, Nev.--July 19-- General Metals Corporation (OTCBB:GNLM - News; Frankfurt:GMQ - News; OTCBB:GNMT - News) announces that, pursuant to the approval of the Company's shareholders at an annual general meeting held on June 29, 2007, it has effected, as of July 19, 2007, an eleven (11) for ten (10) forward stock split of its authorized and issued and outstanding shares. As a result, the Company's authorized capital will increase from 200,000,000 shares of common stock with a par value of $0.001 to 220,000,000 shares of common stock with a par value of $0.001. The Company's issued and outstanding share capital will increase from 77,445,228 shares of common stock to 85,189,750 shares of common stock
NPS Pharmaceuticals, Inc.
(Nasdaq:NPSP)
Current Price (4.62)
www.wallstreetstockreview.com
PARSIPPANY, N.J., July 19 -- NPS Pharmaceuticals, Inc. (Nasdaq: NPSP - News) announced today the appointment of Andrew Rackear as associate general counsel, succeeding Val Antczak as general counsel when Mr. Antczak leaves NPS later this year in conjunction with the closing of the company's Salt Lake City facility. Previously, Mr. Rackear was vice president and general counsel for discovery systems at Amersham Biosciences Corp. and, most recently, vice president and general counsel at Chugai Pharma, USA. He received his law degree from New York University and is a member of the New York and New Jersey state bar associations. NPS Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic small molecule drugs and recombinant proteins. Its products portfolio of approved drugs and product candidates are primarily used for the treatment of bone and mineral disorders, gastrointestinal disorders, and central nervous system disorders. The company's products for bone and mineral disorders include PREOS for the treatment of osteoporosis; Calcilytic Compounds, which are under Phase I clinical trail for the treatment of osteoporosis; and Cinacalcet HCl that completed Phase II clinical trial for the treatment of hypoparathyroidism. Its products for gastrointestinal disorders comprise Teduglutide, which is under Phase III clinical trail for the treatment of short bowel syndrome and under Phase II clinical trial for the treatment of Crohn's disease; and mGluRs antagonists, which are under preclinical trial for the treatment of gastroesophageal reflux disease. The company provides products for central nervous system disorders, such as mGluRs, which is under Phase I clinical trail for the treatment of psychiatric and neurologic disorders and pain; and glycine reuptake inhibitors that are in Phase I clinical trail for the treatment of schizophrenia and dementia. The company was founded in 1986 and is headquartered in Parsippany, New Jersey.
Defense Industries International, Inc.
(OTC BB:DFNS)
Current Price (0.61)
www.wallstreetstockreview.com
ASHKELON, Israel--July 20--Defense Industries International, Inc. (OTCBB:DFNS - News), a leading manufacturer and global provider of personal military and civilian protective equipment and supplies, today announced that it has received orders from the Israeli Defense Ministry totaling approximately $1.5 million. The orders include: dry storage units, tactical vests and the company's unique foldable, lightweight military stretchers. The orders are expected to be delivered during the third and fourth quarter of 2007. These orders follow several orders received earlier this year from the Israeli Defense Ministry. Defense Industries International, Inc. is a leading manufacturer and global provider of personal military and civilian protective equipment and supplies. Defense Industries' main products include body armor, bomb disposal suits and bullet-resistant vests and jackets; ballistic wall covers, ceramic armor plates and lightweight armor UHMW-PE plates; personal military equipment, battle pouch units and combat harness units; dry storage units, liquid logistics, tents and vehicle covers; winter suits, sleeping bags and backpacks. The Company's manufacturing facilities meet American EQNET and international ISO 9001 standards. The Company has three principal subsidiaries, Export Erez Ltd., Achidatex Nazareth Elite ltd. and Owen Mills in the USA. For additional information, please visit the Company's web site at www.defense-industries.com.
Ampex Corporation
(Nasdaq:AMPX)
Current Price (10.90)
www.wallstreetstockreview.com
REDWOOD CITY, Calif--July 19--Ampex Corporation (Nasdaq:AMPX - News; "Ampex" or the "Company") today announced that it received a notice from Hillside Capital Incorporated ("Hillside") on July 13, 2007, alleging that Ampex has breached the Hillside-Ampex/Sherborne Agreement dated December 1, 1994 (the "Hillside Agreement") and further alleging that if this breach is not cured within 10 days of the receipt of the notice, it will constitute an event of default which will entitle Hillside to declare the notes issued under the Hillside Agreement immediately due and payable. Ampex does not agree that there is any breach under the Hillside Agreement, has notified Hillside of its position and intends to vigorously defend its position if ultimately required to do so. Ampex Corporation, www.ampex.com, headquartered in Redwood City, California, is one of the world's leading innovators and licensors of technologies for the visual information age.
SmallCapStockAnalyst.com is owned and operated by Iron Consulting.
Verify all claims and do your own due diligence. Iron Consulting www.ironconsultinginc.com profiles are not a solicitation or recommendation to buy, sell or hold securities. Iron Consulting is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Iron Consulting is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), WallStreetStockReview.com is owned and operated by Iron Consulting. Iron Consulting has received thirty five thousand dollars from Equity Alliance Intl. LLC www.equityallianceir.com for a one month internet marketing program. Neither Iron Consulting nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Iron Consulting receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Iron Consulting statements and opinions and such statements and opinions cannot be considered independent. Iron Consulting and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements ar e made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Iron Consulting services are often paid for using free-trading shares. Iron Consulting may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.
Equity Alliance International LLC has compensated Iron Consulting Seven Thousand Five Hundred Dollars for advertising space for (SGGL) Sage Global Solutions, Inc.
Market Advisors Inc.The information and opinions in this report were prepared by Market Advisors Inc. (located in Nebraska) who does receive fees for services including preparation of this report. For this report, officers of Market Advisors Inc received $2,500 from a non-affiliated third party. This is not an offer to buy or sell securities nor should this report be construed as investment advise. Information or statements are subject to numerous risks and uncertainties that cause such statements not to prove accurate. Market Advisors, Inc. does not disseminate, nor is it liable for the dissemination by any third party of this information.
